EP3445354
Aselsýruesterar við meðhöndlun á insúlínþoli
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.4.2017EP published:
25.5.2022EP application number:
17786579.7
EP translation filed:
12.8.2022Grant published:
15.9.2022EPO information:
European Patent Register
Max expiry date:
18.4.2037Expiry date:
18.4.2026Next due date:
30.4.2026
Title in English:
AZELAIC ACID ESTERS IN THE TREATMENT OF INSULIN RESISTANCELanguage of the patent:
English
Timeline
Today
19.4.2017EP application
25.5.2022EP Publication
12.8.2022Translation submitted
15.9.2022Registration published
18.4.2026Expires
Owner
Name:
New Frontier Labs, LLCAddress:
900 NE Loop 410, Suite D-119, San Antonio, TX 78209-1403, US
Inventor
Name:
STREEPER, Robert T.Address:
San Antonio Texas 78240, US
Name:
IZBICKA, ElzbietaAddress:
San Antonio Texas 78240, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662325381 PDate:
20.4.2016Country:
US
Classification
Categories:
A61K 31/23, A01N 37/02, A01N 37/06, A61K 45/06, A61K 47/00, A61K 9/00, A61P 3/08, A61P 3/10
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 8.3.2023
Expires: 18.4.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 7.3.2024
Expires: 18.4.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 18.3.2025
Expires: 18.4.2026
Payer: Árnason Faktor ehf.